Andrew Owen
Overview
Explore the profile of Andrew Owen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
348
Citations
5186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cressey T, Salvadori N, Rabie H, du Toit S, Than-In-At K, Groenewald M, et al.
J Acquir Immune Defic Syndr
. 2025 Feb;
PMID: 39972540
Background: Dolutegravir dispersible tablets (DTG-DT) are approved for infants ≥4 weeks and ≥3 kg but their suitability for neonates remains unknown. Methods: PETITE-DTG is a Phase I/II, open-label, single center,...
2.
Denton M, Mitreski G, Owen A, Ranatunga D, Lew H, Brooks D, et al.
J Med Imaging Radiat Oncol
. 2025 Feb;
PMID: 39913854
Introduction: Per-oral Image-guided gastrostomy (PIG) is an alternative to conventional radiologically inserted gastrostomy (RIG). PIG is less frequently used in Australia, despite a favourable complication profile reported within the literature....
3.
Neary M, Gallardo-Toledo E, Sharp J, Herriott J, Kijak E, Bramwell C, et al.
Viruses
. 2025 Jan;
16(12.
PMID: 39772148
Favipiravir (FVP) and remdesivir (RDV) have demonstrable antiviral activity against SARS-CoV-2. Here, the efficacy of FVP, RDV, and FVP with RDV (FVP + RDV) in combination was assessed in Syrian...
4.
Cole S, Pertinez H, Butler A, Kerwash E, Bhat S, El-Khateeb E, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770482
Background: The development of long-acting products of a characterized drug substance is of great interest. It is possible to support the development of these products with available clinical data by...
5.
Bevers L, Jensen R, Owen A, Colbers A, Carr D, Burger D
Pharmacogenomics
. 2024 Dec;
25(14-15):623-635.
PMID: 39697075
Background: Dolutegravir (DTG) is an antiviral agent used for the treatment of HIV, however, there is uncertainty over the influence of genetic variation on DTG exposure, and whether it has...
6.
Furl R, Scarsi K, Sayles H, Anderson M, Ofimboudem J, Weld E, et al.
J Viral Hepat
. 2024 Nov;
32(4):e14031.
PMID: 39545599
Despite available curative treatments, global rates of hepatitis C virus (HCV) infection persist with significant burden in low- and middle-income countries (LMICs). Long-acting (LA) antiviral products are in development. This...
7.
Prasanchaimontri I, Manosuthi W, Pertinez H, Owen A, Niyomnaitham S, Sirijatuphat R, et al.
Pharmacol Res Perspect
. 2024 Nov;
12(6):e1233.
PMID: 39509583
This sub-study sought to characterize the pharmacokinetics (PK) of favipiravir (FPV) within Thai adults and quantitatively assess differences in exposure to those previously reported in other populations as a basis...
8.
Kawano-Dourado L, Kristianslund E, Zeraatkar D, Jani M, Makharia G, Hazlewood G, et al.
BMJ
. 2024 Oct;
387:e079830.
PMID: 39467592
Clinical Question: In adult patients with inflammatory bowel disease, inflammatory arthritis (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis), or psoriasis taking biologic drugs, does proactive therapeutic drug monitoring (TDM) improve outcomes as...
9.
Venter W, Gandhi M, Sokhela S, Sikwese K, Bygrave H, Gama L, et al.
Lancet HIV
. 2024 Aug;
11(10):e711-e716.
PMID: 39159655
Large randomised studies of new long-acting medications for the prevention and treatment of HIV have shown high effectiveness and acceptability. Although modelling studies indicate these agents could be fundamental in...
10.
OBrien M, Owen A, Langshur S, Doblin B, Hinami K, Trick W, et al.
JAMA Netw Open
. 2024 Aug;
7(8):e2425919.
PMID: 39102269
No abstract available.